Role of Instruments in Pharmacoeconomics Perspective-An Overview
In health care usually physical scaling is helping in understanding the cure of a disease. In abstract scaling, one has to give his or her own feelings that does not have a fixed scale to compare with, but defined, evaluated and used. Documenting abstract scaling along with physical scaling is gaining its importance to assess a desired outcome achieved or not, which is usually not recorded. In certain circumstances, choice of treatment, therapy is up to the patient. Mathematical equations were established as cost, benefit, utility, effectiveness etc. Policies relating to health care are to increase lifespan of the individual so that losses in productivity or work are minimized. Holistically, in pharmacoeconomics, it is necessary to compile costs and benefits to come to scientific conclusions in selecting a treatment among the choices available and for reimbursements. The current review article illustrates the various approaches, mathematical models and need of abstract scaling for economical effective therapies.
2. Subba Rao B. Pharmaceutical Research Methodology and Bio-statistics: Theory and Practice: Measurement and Scaling. Rev ed. Hyderabad: Pharma Med Press; 2020.
3. Subba Rao B. Pharmaceutical Research Methodology and Bio-statistics: Theory and Practice: Scaling Techniques. Rev ed. Hyderabad: Pharma Med Press; 2020.
4. Rau B. S, Vijaya Ratna. J. A Study on Selected Components of Supply Chain in Pharmaceuticals. The Pharma Review. 2013 Sep-Oct; 65-72.
5. Cronbach’s Alpha: Simple definition, use and interpretation [Internet]. 2014 Dec 08 [cited 2020 Sep 14]. Available from:
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM